By way of derogation from the provisions of the first paragraph of article D. 1221-58, when the Armed Forces Blood Transfusion Centre imports labile blood products with a view to processing them for foreign armed forces, the import authorisation is issued by the Agence nationale de sécurité du médicament et des produits de santé on the basis of a three-year programme and within the limit of a specified maximum overall quantity.
These products must meet the requirements of the regulations of the country concerned and may only be processed under contract by the Armed Forces Blood Transfusion Centre if they meet the requirements of articles D. 1221-6 and D. 1221-7.